Tango Therapeutics (TNGX) Invested Capital: 2020-2025
Historic Invested Capital for Tango Therapeutics (TNGX) over the last 6 years, with Sep 2025 value amounting to $160.0 million.
- Tango Therapeutics' Invested Capital fell 30.17% to $160.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $160.0 million, marking a year-over-year decrease of 30.17%. This contributed to the annual value of $199.5 million for FY2024, which is 21.17% down from last year.
- As of Q3 2025, Tango Therapeutics' Invested Capital stood at $160.0 million, which was up 18.58% from $135.0 million recorded in Q2 2025.
- Over the past 5 years, Tango Therapeutics' Invested Capital peaked at $365.4 million during Q3 2021, and registered a low of $5.0 million during Q1 2021.
- In the last 3 years, Tango Therapeutics' Invested Capital had a median value of $227.3 million in 2023 and averaged $215.7 million.
- As far as peak fluctuations go, Tango Therapeutics' Invested Capital soared by 20,284.90% in 2021, and later tumbled by 45.51% in 2025.
- Tango Therapeutics' Invested Capital (Quarterly) stood at $344.7 million in 2021, then declined by 27.64% to $249.5 million in 2022, then rose by 1.46% to $253.1 million in 2023, then fell by 21.17% to $199.5 million in 2024, then crashed by 30.17% to $160.0 million in 2025.
- Its last three reported values are $160.0 million in Q3 2025, $135.0 million for Q2 2025, and $166.8 million during Q1 2025.